vs
OmniAb, Inc.（OABI）与RETRACTABLE TECHNOLOGIES INC（RVP）财务数据对比。点击上方公司名可切换其他公司
RETRACTABLE TECHNOLOGIES INC的季度营收约是OmniAb, Inc.的1.1倍（$9.4M vs $8.4M），RETRACTABLE TECHNOLOGIES INC净利率更高（-24.9% vs -169.3%，领先144.4%），RETRACTABLE TECHNOLOGIES INC同比增速更快（4.0% vs -22.5%），过去两年RETRACTABLE TECHNOLOGIES INC的营收复合增速更高（11.5% vs -51.3%）
OmniAb, Inc.是一家跨国生物技术企业，拥有专利转基因动物平台及全流程抗体发现解决方案，与全球制药和生物科技公司合作，加速肿瘤、自身免疫病等刚需医疗领域的全人源治疗抗体开发。
Retractable Technologies Inc是一家专业医疗设备制造商，主打可回缩注射器、安全针头、静脉导管等一次性安全医疗产品，客户覆盖医疗机构、制药企业及公共卫生部门，产品可有效降低医护人员与患者的针刺伤害风险。
OABI vs RVP — 直观对比
营收规模更大
RVP
是对方的1.1倍
$8.4M
营收增速更快
RVP
高出26.5%
-22.5%
净利率更高
RVP
高出144.4%
-169.3%
两年增速更快
RVP
近两年复合增速
-51.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.4M | $9.4M |
| 净利润 | $-14.2M | $-2.3M |
| 毛利率 | — | -16.2% |
| 营业利润率 | -188.2% | -81.7% |
| 净利率 | -169.3% | -24.9% |
| 营收同比 | -22.5% | 4.0% |
| 净利润同比 | -8.5% | -162.3% |
| 每股收益（稀释后） | $-0.11 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OABIRVP
| Q4 25 | $8.4M | $9.4M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | $10.8M | $9.1M | ||
| Q3 24 | — | $10.3M | ||
| Q2 24 | $7.6M | $6.0M | ||
| Q1 24 | — | $7.6M |
净利润OABIRVP
| Q4 25 | $-14.2M | $-2.3M | ||
| Q3 25 | — | $371.0K | ||
| Q2 25 | — | $-87.5K | ||
| Q1 25 | — | $-10.5M | ||
| Q4 24 | $-13.1M | $3.8M | ||
| Q3 24 | — | $-1.9M | ||
| Q2 24 | $-13.6M | $-14.2M | ||
| Q1 24 | — | $429.4K |
毛利率OABIRVP
| Q4 25 | — | -16.2% | ||
| Q3 25 | — | 16.7% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | -0.0% | ||
| Q4 24 | — | -27.5% | ||
| Q3 24 | — | -0.1% | ||
| Q2 24 | — | -7.0% | ||
| Q1 24 | — | 25.0% |
营业利润率OABIRVP
| Q4 25 | -188.2% | -81.7% | ||
| Q3 25 | — | -36.2% | ||
| Q2 25 | — | -49.1% | ||
| Q1 25 | — | -56.4% | ||
| Q4 24 | -147.0% | -79.6% | ||
| Q3 24 | — | -49.6% | ||
| Q2 24 | -214.1% | -95.6% | ||
| Q1 24 | — | -39.3% |
净利率OABIRVP
| Q4 25 | -169.3% | -24.9% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | -0.8% | ||
| Q1 25 | — | -126.6% | ||
| Q4 24 | -121.0% | 41.6% | ||
| Q3 24 | — | -18.6% | ||
| Q2 24 | -179.0% | -234.9% | ||
| Q1 24 | — | 5.7% |
每股收益（稀释后）OABIRVP
| Q4 25 | $-0.11 | $-0.09 | ||
| Q3 25 | — | $0.01 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | $-0.13 | $0.14 | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | $-0.13 | $-0.48 | ||
| Q1 24 | — | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $25.5M | $2.6M |
| 总债务越低越好 | — | $895.6K |
| 股东权益账面价值 | $267.0M | $74.4M |
| 总资产 | $300.9M | $142.6M |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资OABIRVP
| Q4 25 | $25.5M | $2.6M | ||
| Q3 25 | — | $3.4M | ||
| Q2 25 | — | $3.0M | ||
| Q1 25 | — | $3.4M | ||
| Q4 24 | $27.6M | $4.2M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | $20.8M | $6.9M | ||
| Q1 24 | — | $10.0M |
总债务OABIRVP
| Q4 25 | — | $895.6K | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益OABIRVP
| Q4 25 | $267.0M | $74.4M | ||
| Q3 25 | — | $76.8M | ||
| Q2 25 | — | $76.5M | ||
| Q1 25 | — | $76.6M | ||
| Q4 24 | $287.6M | $87.2M | ||
| Q3 24 | — | $83.5M | ||
| Q2 24 | $294.2M | $85.4M | ||
| Q1 24 | — | $99.7M |
总资产OABIRVP
| Q4 25 | $300.9M | $142.6M | ||
| Q3 25 | — | $146.4M | ||
| Q2 25 | — | $147.1M | ||
| Q1 25 | — | $149.3M | ||
| Q4 24 | $325.6M | $160.7M | ||
| Q3 24 | — | $157.8M | ||
| Q2 24 | $337.3M | $160.7M | ||
| Q1 24 | — | $176.0M |
负债/权益比OABIRVP
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-596.5K |
| 自由现金流经营现金流 - 资本支出 | $-5.7M | — |
| 自由现金流率自由现金流/营收 | -67.8% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-31.8M | — |
8季度趋势，按日历期对齐
经营现金流OABIRVP
| Q4 25 | $-5.7M | $-596.5K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $-3.7M | ||
| Q1 25 | — | $-1.5M | ||
| Q4 24 | $-3.9M | $-1.1M | ||
| Q3 24 | — | $-5.7M | ||
| Q2 24 | $-12.2M | $-2.7M | ||
| Q1 24 | — | $-2.0M |
自由现金流OABIRVP
| Q4 25 | $-5.7M | — | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | $-3.9M | $-1.4M | ||
| Q3 24 | — | $-6.5M | ||
| Q2 24 | $-12.9M | $-2.8M | ||
| Q1 24 | — | $-2.2M |
自由现金流率OABIRVP
| Q4 25 | -67.8% | — | ||
| Q3 25 | — | -13.4% | ||
| Q2 25 | — | -38.9% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | -36.3% | -15.5% | ||
| Q3 24 | — | -63.0% | ||
| Q2 24 | -169.9% | -46.8% | ||
| Q1 24 | — | -29.6% |
资本支出强度OABIRVP
| Q4 25 | 0.1% | — | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 0.4% | 3.3% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | 9.9% | 2.0% | ||
| Q1 24 | — | 3.0% |
现金转化率OABIRVP
| Q4 25 | — | — | ||
| Q3 25 | — | -3.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -4.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
